English
简体中文
Total: £ 56.28
Published Date: 2026-04-07 | Pages: 104 | Tables: 109 | Medical Care
The global Lipid Nanoparticles (LNP) market was valued at US$ 537 million in 2025 and is anticipated to reach US$ 874 million by 2032, at a CAGR of 7.3% from 2026 to 2032.
LNPs are liposome-like structures especially geared towards encapsulating a broad variety of nucleic acids (RNA and DNA); and as such, they are the most popular non-viral gene delivery system. Exelead develops and manufactures LNPs to encapsulate different types of genetic payloads including siRNA, mRNA and saRNA.
The growing adoption of lipid nanoparticles (LNP) in drug delivery systems is a major driver of market growth. LNPs have become essential in mRNA-based therapies, particularly highlighted by their role in COVID-19 vaccines. Their ability to efficiently deliver genetic material, small molecules, and biologics while ensuring stability and targeted release has made them a cornerstone in advanced pharmaceutical applications. Additionally, increasing research on LNP applications in cancer treatment, gene therapy, and rare diseases is accelerating demand. The rising prevalence of chronic diseases and the need for precision medicine further bolster the market's expansion.
Despite their promising applications, the LNP market faces challenges such as high production costs and complex manufacturing processes. Scaling up production while maintaining the quality and consistency of LNP formulations remains a significant hurdle. Moreover, stringent regulatory requirements for approval and safety testing can slow down commercialization. Limited understanding of potential long-term effects and toxicity in vivo also poses concerns for researchers and manufacturers. Addressing these challenges is critical to ensuring the widespread adoption and success of LNP-based therapeutics in the market.
The world's core manufacturers of Lipid Nanoparticles include Merck KGaA and others. The largest manufacturer has approximately 70% of the market share. North America is the world's largest market, accounting for approximately 60% of the market, followed by Europe and Asia Pacific, accounting for 26% and 9%, respectively. Among them, mRNA-lipid nanoparticles and siRNA-lipid nanoparticles accounted for 93% and 5%, respectively. The most used are vaccine drugs and scientific research, accounting for 81% and 19% respectively.
This report delivers a comprehensive overview of the global Lipid Nanoparticles (LNP) market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Lipid Nanoparticles (LNP). The Lipid Nanoparticles (LNP) market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Lipid Nanoparticles (LNP) market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Lipid Nanoparticles (LNP) manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Precision NanoSystems
Evonik
Merck KGaA
Genevant Sciences
Exelead
Avanti Polar Lipids
Nippon Fine Chemical
Lipoid
Segment by Type
mRNA-lipid Nanoparticle
siRNA-lipid Nanoparticle
Others
Segment by Application
Vaccines and Drugs
Scientific Research
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Lipid Nanoparticles (LNP) companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Lipid Nanoparticles (LNP) Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 mRNA-lipid Nanoparticle
1.2.3 siRNA-lipid Nanoparticle
1.2.4 Others
1.3 Market by Application
1.3.1 Global Lipid Nanoparticles (LNP) Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Vaccines and Drugs
1.3.3 Scientific Research
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Lipid Nanoparticles (LNP) Market Perspective (2021–2032)
2.2 Global Lipid Nanoparticles (LNP) Growth Trends by Region
2.2.1 Global Lipid Nanoparticles (LNP) Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Lipid Nanoparticles (LNP) Historic Market Size by Region (2021–2026)
2.2.3 Lipid Nanoparticles (LNP) Forecasted Market Size by Region (2027–2032)
2.3 Lipid Nanoparticles (LNP) Market Dynamics
2.3.1 Lipid Nanoparticles (LNP) Industry Trends
2.3.2 Lipid Nanoparticles (LNP) Market Drivers
2.3.3 Lipid Nanoparticles (LNP) Market Challenges
2.3.4 Lipid Nanoparticles (LNP) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Lipid Nanoparticles (LNP) Players by Revenue
3.1.1 Global Top Lipid Nanoparticles (LNP) Players by Revenue (2021–2026)
3.1.2 Global Lipid Nanoparticles (LNP) Revenue Market Share by Players (2021–2026)
3.2 Global Top Lipid Nanoparticles (LNP) Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Lipid Nanoparticles (LNP) Revenue
3.4 Global Lipid Nanoparticles (LNP) Market Concentration Ratio
3.4.1 Global Lipid Nanoparticles (LNP) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Lipid Nanoparticles (LNP) Revenue in 2025
3.5 Global Key Players of Lipid Nanoparticles (LNP) Head Offices and Areas Served
3.6 Global Key Players of Lipid Nanoparticles (LNP), Products and Applications
3.7 Global Key Players of Lipid Nanoparticles (LNP), Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Lipid Nanoparticles (LNP) Breakdown Data by Type
4.1 Global Lipid Nanoparticles (LNP) Historic Market Size by Type (2021–2026)
4.2 Global Lipid Nanoparticles (LNP) Forecasted Market Size by Type (2027–2032)
5 Lipid Nanoparticles (LNP) Breakdown Data by Application
5.1 Global Lipid Nanoparticles (LNP) Historic Market Size by Application (2021–2026)
5.2 Global Lipid Nanoparticles (LNP) Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Lipid Nanoparticles (LNP) Market Size (2021–2032)
6.2 North America Lipid Nanoparticles (LNP) Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Lipid Nanoparticles (LNP) Market Size by Country (2021–2026)
6.4 North America Lipid Nanoparticles (LNP) Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Lipid Nanoparticles (LNP) Market Size (2021–2032)
7.2 Europe Lipid Nanoparticles (LNP) Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Lipid Nanoparticles (LNP) Market Size by Country (2021–2026)
7.4 Europe Lipid Nanoparticles (LNP) Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Lipid Nanoparticles (LNP) Market Size (2021–2032)
8.2 Asia-Pacific Lipid Nanoparticles (LNP) Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Lipid Nanoparticles (LNP) Market Size by Region (2021–2026)
8.4 Asia-Pacific Lipid Nanoparticles (LNP) Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Lipid Nanoparticles (LNP) Market Size (2021–2032)
9.2 Latin America Lipid Nanoparticles (LNP) Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Lipid Nanoparticles (LNP) Market Size by Country (2021–2026)
9.4 Latin America Lipid Nanoparticles (LNP) Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Lipid Nanoparticles (LNP) Market Size (2021–2032)
10.2 Middle East & Africa Lipid Nanoparticles (LNP) Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Lipid Nanoparticles (LNP) Market Size by Country (2021–2026)
10.4 Middle East & Africa Lipid Nanoparticles (LNP) Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Precision NanoSystems
11.1.1 Precision NanoSystems Company Details
11.1.2 Precision NanoSystems Business Overview
11.1.3 Precision NanoSystems Lipid Nanoparticles (LNP) Introduction
11.1.4 Precision NanoSystems Revenue in Lipid Nanoparticles (LNP) Business (2021–2026)
11.1.5 Precision NanoSystems Recent Development
11.2 Evonik
11.2.1 Evonik Company Details
11.2.2 Evonik Business Overview
11.2.3 Evonik Lipid Nanoparticles (LNP) Introduction
11.2.4 Evonik Revenue in Lipid Nanoparticles (LNP) Business (2021–2026)
11.2.5 Evonik Recent Development
11.3 Merck KGaA
11.3.1 Merck KGaA Company Details
11.3.2 Merck KGaA Business Overview
11.3.3 Merck KGaA Lipid Nanoparticles (LNP) Introduction
11.3.4 Merck KGaA Revenue in Lipid Nanoparticles (LNP) Business (2021–2026)
11.3.5 Merck KGaA Recent Development
11.4 Genevant Sciences
11.4.1 Genevant Sciences Company Details
11.4.2 Genevant Sciences Business Overview
11.4.3 Genevant Sciences Lipid Nanoparticles (LNP) Introduction
11.4.4 Genevant Sciences Revenue in Lipid Nanoparticles (LNP) Business (2021–2026)
11.4.5 Genevant Sciences Recent Development
11.5 Exelead
11.5.1 Exelead Company Details
11.5.2 Exelead Business Overview
11.5.3 Exelead Lipid Nanoparticles (LNP) Introduction
11.5.4 Exelead Revenue in Lipid Nanoparticles (LNP) Business (2021–2026)
11.5.5 Exelead Recent Development
11.6 Avanti Polar Lipids
11.6.1 Avanti Polar Lipids Company Details
11.6.2 Avanti Polar Lipids Business Overview
11.6.3 Avanti Polar Lipids Lipid Nanoparticles (LNP) Introduction
11.6.4 Avanti Polar Lipids Revenue in Lipid Nanoparticles (LNP) Business (2021–2026)
11.6.5 Avanti Polar Lipids Recent Development
11.7 Nippon Fine Chemical
11.7.1 Nippon Fine Chemical Company Details
11.7.2 Nippon Fine Chemical Business Overview
11.7.3 Nippon Fine Chemical Lipid Nanoparticles (LNP) Introduction
11.7.4 Nippon Fine Chemical Revenue in Lipid Nanoparticles (LNP) Business (2021–2026)
11.7.5 Nippon Fine Chemical Recent Development
11.8 Lipoid
11.8.1 Lipoid Company Details
11.8.2 Lipoid Business Overview
11.8.3 Lipoid Lipid Nanoparticles (LNP) Introduction
11.8.4 Lipoid Revenue in Lipid Nanoparticles (LNP) Business (2021–2026)
11.8.5 Lipoid Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Lipid Nanoparticles (LNP) Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of mRNA-lipid Nanoparticle
Table 3. Key Players of siRNA-lipid Nanoparticle
Table 4. Key Players of Others
Table 5. Global Lipid Nanoparticles (LNP) Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 6. Global Lipid Nanoparticles (LNP) Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 7. Global Lipid Nanoparticles (LNP) Market Size by Region (US$ Million), 2021–2026
Table 8. Global Lipid Nanoparticles (LNP) Market Share by Region (2021–2026)
Table 9. Global Lipid Nanoparticles (LNP) Forecasted Market Size by Region (US$ Million), 2027–2032
Table 10. Global Lipid Nanoparticles (LNP) Market Share by Region (2027–2032)
Table 11. Lipid Nanoparticles (LNP) Market Trends
Table 12. Lipid Nanoparticles (LNP) Market Drivers
Table 13. Lipid Nanoparticles (LNP) Market Challenges
Table 14. Lipid Nanoparticles (LNP) Market Restraints
Table 15. Global Lipid Nanoparticles (LNP) Revenue by Players (US$ Million), 2021–2026
Table 16. Global Lipid Nanoparticles (LNP) Market Share by Players (2021–2026)
Table 17. Global Top Lipid Nanoparticles (LNP) Players by Tier (Tier 1, Tier 2, and Tier 3), based on Lipid Nanoparticles (LNP) Revenue, 2025
Table 18. Ranking of Global Top Lipid Nanoparticles (LNP) Companies by Revenue (US$ Million) in 2025
Table 19. Global 5 Largest Players Market Share by Lipid Nanoparticles (LNP) Revenue (CR5 and HHI), 2021–2026
Table 20. Global Key Players of Lipid Nanoparticles (LNP), Headquarters and Area Served
Table 21. Global Key Players of Lipid Nanoparticles (LNP), Products and Applications
Table 22. Global Key Players of Lipid Nanoparticles (LNP), Date of General Availability (GA)
Table 23. Mergers and Acquisitions, Expansion Plans
Table 24. Global Lipid Nanoparticles (LNP) Market Size by Type (US$ Million), 2021–2026
Table 25. Global Lipid Nanoparticles (LNP) Revenue Market Share by Type (2021–2026)
Table 26. Global Lipid Nanoparticles (LNP) Forecasted Market Size by Type (US$ Million), 2027–2032
Table 27. Global Lipid Nanoparticles (LNP) Revenue Market Share by Type (2027–2032)
Table 28. Global Lipid Nanoparticles (LNP) Market Size by Application (US$ Million), 2021–2026
Table 29. Global Lipid Nanoparticles (LNP) Revenue Market Share by Application (2021–2026)
Table 30. Global Lipid Nanoparticles (LNP) Forecasted Market Size by Application (US$ Million), 2027–2032
Table 31. Global Lipid Nanoparticles (LNP) Revenue Market Share by Application (2027–2032)
Table 32. North America Lipid Nanoparticles (LNP) Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 33. North America Lipid Nanoparticles (LNP) Market Size by Country (US$ Million), 2021–2026
Table 34. North America Lipid Nanoparticles (LNP) Market Size by Country (US$ Million), 2027–2032
Table 35. Europe Lipid Nanoparticles (LNP) Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 36. Europe Lipid Nanoparticles (LNP) Market Size by Country (US$ Million), 2021–2026
Table 37. Europe Lipid Nanoparticles (LNP) Market Size by Country (US$ Million), 2027–2032
Table 38. Asia-Pacific Lipid Nanoparticles (LNP) Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 39. Asia-Pacific Lipid Nanoparticles (LNP) Market Size by Region (US$ Million), 2021–2026
Table 40. Asia-Pacific Lipid Nanoparticles (LNP) Market Size by Region (US$ Million), 2027–2032
Table 41. Latin America Lipid Nanoparticles (LNP) Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 42. Latin America Lipid Nanoparticles (LNP) Market Size by Country (US$ Million), 2021–2026
Table 43. Latin America Lipid Nanoparticles (LNP) Market Size by Country (US$ Million), 2027–2032
Table 44. Middle East & Africa Lipid Nanoparticles (LNP) Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 45. Middle East & Africa Lipid Nanoparticles (LNP) Market Size by Country (US$ Million), 2021–2026
Table 46. Middle East & Africa Lipid Nanoparticles (LNP) Market Size by Country (US$ Million), 2027–2032
Table 47. Precision NanoSystems Company Details
Table 48. Precision NanoSystems Business Overview
Table 49. Precision NanoSystems Lipid Nanoparticles (LNP) Product
Table 50. Precision NanoSystems Revenue in Lipid Nanoparticles (LNP) Business (US$ Million), 2021–2026
Table 51. Precision NanoSystems Recent Development
Table 52. Evonik Company Details
Table 53. Evonik Business Overview
Table 54. Evonik Lipid Nanoparticles (LNP) Product
Table 55. Evonik Revenue in Lipid Nanoparticles (LNP) Business (US$ Million), 2021–2026
Table 56. Evonik Recent Development
Table 57. Merck KGaA Company Details
Table 58. Merck KGaA Business Overview
Table 59. Merck KGaA Lipid Nanoparticles (LNP) Product
Table 60. Merck KGaA Revenue in Lipid Nanoparticles (LNP) Business (US$ Million), 2021–2026
Table 61. Merck KGaA Recent Development
Table 62. Genevant Sciences Company Details
Table 63. Genevant Sciences Business Overview
Table 64. Genevant Sciences Lipid Nanoparticles (LNP) Product
Table 65. Genevant Sciences Revenue in Lipid Nanoparticles (LNP) Business (US$ Million), 2021–2026
Table 66. Genevant Sciences Recent Development
Table 67. Exelead Company Details
Table 68. Exelead Business Overview
Table 69. Exelead Lipid Nanoparticles (LNP) Product
Table 70. Exelead Revenue in Lipid Nanoparticles (LNP) Business (US$ Million), 2021–2026
Table 71. Exelead Recent Development
Table 72. Avanti Polar Lipids Company Details
Table 73. Avanti Polar Lipids Business Overview
Table 74. Avanti Polar Lipids Lipid Nanoparticles (LNP) Product
Table 75. Avanti Polar Lipids Revenue in Lipid Nanoparticles (LNP) Business (US$ Million), 2021–2026
Table 76. Avanti Polar Lipids Recent Development
Table 77. Nippon Fine Chemical Company Details
Table 78. Nippon Fine Chemical Business Overview
Table 79. Nippon Fine Chemical Lipid Nanoparticles (LNP) Product
Table 80. Nippon Fine Chemical Revenue in Lipid Nanoparticles (LNP) Business (US$ Million), 2021–2026
Table 81. Nippon Fine Chemical Recent Development
Table 82. Lipoid Company Details
Table 83. Lipoid Business Overview
Table 84. Lipoid Lipid Nanoparticles (LNP) Product
Table 85. Lipoid Revenue in Lipid Nanoparticles (LNP) Business (US$ Million), 2021–2026
Table 86. Lipoid Recent Development
Table 87. Research Programs/Design for This Report
Table 88. Key Data Information from Secondary Sources
Table 89. Key Data Information from Primary Sources
Table 90. Authors List of This Report
List of Figures
Figure 1. Lipid Nanoparticles (LNP) Picture
Figure 2. Global Lipid Nanoparticles (LNP) Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Lipid Nanoparticles (LNP) Market Share by Type: 2025 vs 2032
Figure 4. mRNA-lipid Nanoparticle Features
Figure 5. siRNA-lipid Nanoparticle Features
Figure 6. Others Features
Figure 7. Global Lipid Nanoparticles (LNP) Market Size by Application (US$ Million), 2021–2032
Figure 8. Global Lipid Nanoparticles (LNP) Market Share by Application: 2025 vs 2032
Figure 9. Vaccines and Drugs Case Studies
Figure 10. Scientific Research Case Studies
Figure 11. Lipid Nanoparticles (LNP) Report Years Considered
Figure 12. Global Lipid Nanoparticles (LNP) Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 13. Global Lipid Nanoparticles (LNP) Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 14. Global Lipid Nanoparticles (LNP) Market Share by Region: 2025 vs 2032
Figure 15. Global Lipid Nanoparticles (LNP) Market Share by Players in 2025
Figure 16. Global Lipid Nanoparticles (LNP) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 17. The Top 10 and 5 Players Market Share by Lipid Nanoparticles (LNP) Revenue in 2025
Figure 18. North America Lipid Nanoparticles (LNP) Market Size YoY Growth (US$ Million), 2021–2032
Figure 19. North America Lipid Nanoparticles (LNP) Market Share by Country (2021–2032)
Figure 20. United States Lipid Nanoparticles (LNP) Market Size YoY Growth (US$ Million), 2021–2032
Figure 21. Canada Lipid Nanoparticles (LNP) Market Size YoY Growth (US$ Million), 2021–2032
Figure 22. Europe Lipid Nanoparticles (LNP) Market Size YoY Growth (US$ Million), 2021–2032
Figure 23. Europe Lipid Nanoparticles (LNP) Market Share by Country (2021–2032)
Figure 24. Germany Lipid Nanoparticles (LNP) Market Size YoY Growth (US$ Million), 2021–2032
Figure 25. France Lipid Nanoparticles (LNP) Market Size YoY Growth (US$ Million), 2021–2032
Figure 26. U.K. Lipid Nanoparticles (LNP) Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. Italy Lipid Nanoparticles (LNP) Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. Russia Lipid Nanoparticles (LNP) Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. Ireland Lipid Nanoparticles (LNP) Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Asia-Pacific Lipid Nanoparticles (LNP) Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Asia-Pacific Lipid Nanoparticles (LNP) Market Share by Region (2021–2032)
Figure 32. China Lipid Nanoparticles (LNP) Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. Japan Lipid Nanoparticles (LNP) Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. South Korea Lipid Nanoparticles (LNP) Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. Southeast Asia Lipid Nanoparticles (LNP) Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. India Lipid Nanoparticles (LNP) Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. Australia & New Zealand Lipid Nanoparticles (LNP) Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. Latin America Lipid Nanoparticles (LNP) Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Latin America Lipid Nanoparticles (LNP) Market Share by Country (2021–2032)
Figure 40. Mexico Lipid Nanoparticles (LNP) Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. Brazil Lipid Nanoparticles (LNP) Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Middle East & Africa Lipid Nanoparticles (LNP) Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Middle East & Africa Lipid Nanoparticles (LNP) Market Share by Country (2021–2032)
Figure 44. Israel Lipid Nanoparticles (LNP) Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. Saudi Arabia Lipid Nanoparticles (LNP) Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. UAE Lipid Nanoparticles (LNP) Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. Precision NanoSystems Revenue Growth Rate in Lipid Nanoparticles (LNP) Business (2021–2026)
Figure 48. Evonik Revenue Growth Rate in Lipid Nanoparticles (LNP) Business (2021–2026)
Figure 49. Merck KGaA Revenue Growth Rate in Lipid Nanoparticles (LNP) Business (2021–2026)
Figure 50. Genevant Sciences Revenue Growth Rate in Lipid Nanoparticles (LNP) Business (2021–2026)
Figure 51. Exelead Revenue Growth Rate in Lipid Nanoparticles (LNP) Business (2021–2026)
Figure 52. Avanti Polar Lipids Revenue Growth Rate in Lipid Nanoparticles (LNP) Business (2021–2026)
Figure 53. Nippon Fine Chemical Revenue Growth Rate in Lipid Nanoparticles (LNP) Business (2021–2026)
Figure 54. Lipoid Revenue Growth Rate in Lipid Nanoparticles (LNP) Business (2021–2026)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed
